Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 5 - Drugs for disorders of the endocrine system
Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908)
11/2012
11/22/2012WO2012157746A1 Therapeutic drug for autoimmune disease
11/22/2012WO2012156822A1 Controlled release nasal testosterone gels, methods and pre-filled multi-dose applicator systems for pernasal administration
11/22/2012WO2012156821A1 Intranasal lower dosage strength testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder
11/22/2012WO2012156820A1 Intranasal testosterone bio-adhesive gel formulations and use thereof for treating male hypogonadism
11/22/2012US20120295953 Treatment of tumor protein 63 (p63) related diseases by inhibition of natural antisense transcript to p63
11/22/2012US20120295943 Cycloalkylamine derivatives
11/22/2012US20120295900 1,3-oxazines as bace 1 and/or bace2 inhibitors
11/22/2012US20120295888 Use of an adrenal hormone-modifying agent
11/22/2012US20120295848 Sustained-release composition and process for producing the same
11/22/2012US20120294895 Protein a compositions and methods of use
11/22/2012US20120294861 Fgfr1 agonists and methods of use
11/22/2012CA2836573A1 Improved peptide pharmaceuticals
11/22/2012CA2836405A1 Controlled release nasal testosterone gels, methods and pre-filled multi-dose applicator systems for pernasal administration
11/22/2012CA2836398A1 Intranasal testosterone bio-adhesive gel formulations and use thereof for treating male hypogonadism
11/22/2012CA2835911A1 Intranasal lower dosage strength testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder
11/21/2012EP2524917A1 Fused pyridine derivatives
11/21/2012EP2523731A1 Use of an adrenal hormone-modifying agent
11/21/2012CN102791282A Orally administerable pharmaceutical preparation containing insulin
11/21/2012CN102786574A Glycyrrhetinic acid crystal A substance, its preparation method, and its applications in medicines and healthcare products
11/21/2012CN102786573A Glycyrrhetinic acid crystal B substance, its preparation method, and its applications in medicines and healthcare products
11/21/2012CN102784143A Single layer osmotic pump controlled release preparation containing metoprolol and felodipine
11/21/2012CN102784106A Oral calcitonin liposome and lyophilized preparation thereof
11/21/2012CN102233059B Chinese medicinal composition for regulating female estrogen level and delaying senility and preparation method
11/21/2012CN102188514B Application of medicinal composition in process of preparing medicine for preventing and treating hyperprolactinemia
11/21/2012CN102008474B Application of nitidine chloride to preparation of medicament for treating autoimmune disease and graft rejection disease
11/21/2012CN102008468B Application of Incarvillea delavay alkali in preparing drug for resisting autoimmune diseases and graft rejection diseases
11/21/2012CN101912487B Medicament for treating neuroendocrine disturbance, sexual function decline and skin aging
11/21/2012CN101637462B Compositions for conjugated estrogens and associated methods
11/15/2012WO2012153729A1 Heteroaromatic ring derivative
11/15/2012US20120289614 Functionalized biodegradable triclosan monomers and oligomers for controlled release
11/15/2012US20120289551 Mineralocorticoid receptor antagonists
11/15/2012US20120289512 Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme
11/15/2012US20120289460 Agonists of Guanylate Cyclase Useful for the Treatment of Hypercholesterolemia, Atherosclerosis, Coronary Heart Disease, Gallstone, Obesity and Other Cardiovascular Diseases
11/15/2012US20120289453 Novel glp-1 compounds
11/15/2012US20120288512 Anti-CD70 Antibody-Drug Conjugates and Their Use for the Treatment of Cancer and Immune Disorders
11/15/2012US20120288493 Method of inhibitng complement activation with human anti-factor c3 antibodies and use thereof
11/15/2012US20120288492 NOVEL PYRIMIDINE COMPOUNDS AS mTOR AND PI3K INHIBITORS
11/15/2012US20120288485 Use of jasmone for modulating melatonin production and calcification of the pineal gland
11/14/2012CN102781910A Alkylamine derivative
11/14/2012CN102775389A Preparation method of N-substituted-4-(7-chloro-quinoline -4-amino)-benzamide derivatives, and application thereof
11/14/2012CN102772653A Tablets for nourishing yin and tonifying blood
11/14/2012CN102772494A Testosterone
11/14/2012CN102772423A Application of amygdalin for ischemia heart protection
11/14/2012CN102772417A Period effect percutaneous patch of self viscosity elastic body substrate containing testosterone and preparation method thereof
11/14/2012CN102772414A S-mirtazapine for the treatment of hot flush
11/14/2012CN102772364A Fat emulsion of Paricalcitol, its preparation and preparation methods thereof
11/14/2012CN101842083B LH liquid formulations
11/14/2012CN101821235B Pyrrolidin-2 -one derivatives as androgen receptor modulator
11/14/2012CN101716135B Soy isoflavone solid dispersion suppository and preparation method thereof
11/13/2012US8309609 Use of benzylideneaminoguanidines and hydroxyguanidines as melanocortin receptor ligands
11/08/2012WO2012151420A1 2α-METHYL AND 2β-METHYL ANALOGS OF 19,26-DINOR-1α, 25-DIHYDROXYVITAMIN D3 AND THEIR USES
11/08/2012WO2012150707A1 Low molecular weight compound which promotes induction of differentiation of stem cells into insulin-producing cells and method for inducing differentiation of stem cells into insulin-producing cells using low molecular weight compound
11/08/2012WO2012150676A1 Synthetic peptide capable of inducing expression of type-2 tnf receptor and use thereof
11/08/2012WO2012083112A3 C- 17 -heteroaryl steroidal compounds as inhibitors of cyp11b, cyp17, and/or cyp21
11/08/2012WO2012053003A9 A novel herbal oil for controlling blood sugar without risk of hypoglycemea
11/08/2012US20120283308 Animal feed composition
11/08/2012US20120283307 Use of an indazolemethoxyalkanoic acid for reducing triglyceride, cholesterol and glucose levels
11/08/2012US20120283303 Use of n-aminoimidazole cytoprotective compounds for treating cell death and/or gsk-3 mediated diseases
11/08/2012US20120283225 Combination Therapy for Skin Disorders
11/08/2012US20120283203 Methods and compositions for the treatment of obesity, insulin related diseases and hypercholesterolemia
11/08/2012US20120283187 Controlled release composition and method of producing the same
11/08/2012US20120282340 Drug delivery system
11/08/2012US20120282279 Anti-Diabetic Compounds
11/07/2012EP2520301A2 Parenteral pharmaceutical formulation in suspension, having sustained release, in low and ultralow dosage, in hormonal therapy in the climacteric syndrome
11/07/2012CN102770414A [5,6] heterocyclic compound
11/07/2012CN102764366A Traditional Chinese medicine for treating chronic lymphatic thyroiditis
11/07/2012CN102764315A Medicine for treating goiter
11/07/2012CN102764262A Application of oleanolic acid and retinoic acid pharmaceutical composition to medicament for treating insulin resistance and diabetes
11/07/2012CN102764239A Propylthiouracil sustained release pellet
11/07/2012CN101528707B 2-[1-phenyl-5-hydroxy or methoxy-4alpha-methyl-hexahydroclopenta[f]indazol-5-yl]ethyl phenyl derivatives as glucocorticoid receptor ligands
11/06/2012US8304453 Composition comprising at least one alkanolamide to inhibit migration of langerhans cells and uses therof
11/06/2012US8304414 Pyrazole compounds useful as protein kinase inhibitors
11/06/2012CA2710409C 6h-dibenz0 [b,e] oxepine derived nonsteroidal mineralocorticoid receptor antagonists
11/01/2012WO2012145809A1 Pharmaceutical compositions and uses thereof for the treatment and/or prevention of diseases caused by hypoestrogenism in the lower genital tract of women
11/01/2012WO2012119004A3 Parathyroid hormone analogs, compositions and uses thereof
11/01/2012US20120277240 Substituted aminotetrahydrothiopyrans and derivatives thereof as dipeptidyl peptidase-iv inhibitors for the treatment of diabetes
11/01/2012US20120277201 Use of hydroxyprogesterone derivatives for enhancing health and physical performance
11/01/2012US20120277171 Warmi®, natural alternative for the treatment of menopause
11/01/2012US20120277169 Nyasol and analogs thereof for the treatment of estrogen receptor beta-mediated diseases
11/01/2012US20120277142 Modified human tumor necrosis factor receptor-1 polypeptide or fragment thereof, and method for preparing same
11/01/2012US20120276215 Therapeutic Conditioned Media
11/01/2012US20120276212 Composition comprising plant and/or fish oils and non-oxidizable fatty acid entities
11/01/2012US20120276194 Pharmaceutical composition based on micronized progesterone, preparation method and uses thereof
11/01/2012US20120276143 Probiotic bifidobacterium strain
11/01/2012US20120276097 Immunoglobulin fusion proteins
10/2012
10/31/2012EP2517718A2 Treatment of T-cell mediated diseases
10/31/2012EP2516400A1 Phenol derivatives and the pharmaceutical or cosmetic use thereof
10/31/2012EP2155757B1 New progesterone receptor modulators
10/31/2012CN102757461A Modified lecithin complexed iodine, and preparation method and application thereof
10/31/2012CN102757441A Furano[3,2-g]chromene compounds and applications thereof
10/31/2012CN102757415A Inhibitor of sodium-dependent glucose transport protein and preparation method therefor and use thereof
10/31/2012CN102757389A 雄激素受体拮抗剂及其用途 Androgen receptor antagonists and their use
10/31/2012CN102755593A Traditional Chinese medicine composition for treating qi goiter and preparation method thereof
10/31/2012CN101679317B Novel 1,2,3,4-tetrahydroquinoxaline derivative which has, as substituent, phenyl group having sulfonic acid ester structure or sulfonic acid amide structure introduced therein and has glucocorticoid receptor binding activity
10/31/2012CN101511857B 18-methyl-19-nor-androst-4-en-17,17-spiroether (18-methyl-19-nor-20- spirox-4-en-3-one) and pharmaceutical preparations containing the same
10/26/2012WO2012144478A1 Tetrahydrothiazepine derivative
10/26/2012WO2012143143A1 Heterocyclic compounds as kinase inhibitors
10/26/2012WO2012143041A1 Composition, method for its manufacture and use thereof
10/26/2012CA2831680A1 Heterocyclic compounds as kinase inhibitors
10/25/2012US20120270949 Melt-granulated cinacalcet
1 ... 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 ... 290